2,250
Participants
Start Date
January 30, 2025
Primary Completion Date
January 31, 2026
Study Completion Date
February 28, 2026
Tadalafil 5 mg tablets with a digital tool.
The combination product will be a Drug (Tadalafil 5 mg) and Health Survey Assessment (as a mandatory digital tool). Tadalafil 5 mg will be taken orally, 1 tablet daily to use for treatment of erectile dysfunction. This study will be conducted remotely, via video interaction.
RECRUITING
Pegus, Salt Lake City
Lead Sponsor
Sanofi
INDUSTRY